175 related articles for article (PubMed ID: 36053326)
21. Serum sHLA-G: Significant diagnostic biomarker with respect to therapy and immunosuppressive mediators in Head and Neck Squamous Cell Carcinoma.
Agnihotri V; Gupta A; Kumar L; Dey S
Sci Rep; 2020 Mar; 10(1):3806. PubMed ID: 32123232
[TBL] [Abstract][Full Text] [Related]
22. Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
Kirana C; Ruszkiewicz A; Stubbs RS; Hardingham JE; Hewett PJ; Maddern GJ; Hauben E
Int J Cancer; 2017 Jun; 140(11):2577-2586. PubMed ID: 28233298
[TBL] [Abstract][Full Text] [Related]
23. The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.
König L; Kasimir-Bauer S; Hoffmann O; Bittner AK; Wagner B; Manvailer LF; Schramm S; Bankfalvi A; Giebel B; Kimmig R; Horn PA; Rebmann V
Hum Immunol; 2016 Sep; 77(9):791-9. PubMed ID: 26796737
[TBL] [Abstract][Full Text] [Related]
24. The impact of IL10 polymorphisms and sHLA-G levels on the risk of schizophrenia.
Rajasekaran A; Shivakumar V; Kalmady SV; Narayanaswamy JC; Subbana M; Venugopal D; Amaresha AC; Venkatasubramanian G; Debnath M
Asian J Psychiatr; 2016 Oct; 23():39-43. PubMed ID: 27969076
[TBL] [Abstract][Full Text] [Related]
25. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease: a noninvasive diagnostic tool?
Rizzo R; Melchiorri L; Simone L; Stignani M; Marzola A; Gullini S; Baricordi OR
Inflamm Bowel Dis; 2008 Jan; 14(1):100-5. PubMed ID: 17886287
[TBL] [Abstract][Full Text] [Related]
26. Decreased production of human leukocyte antigen G molecules in sinonasal polyposis.
Malagutti N; Aimoni C; Balboni A; Stignani M; Melchiorri L; Borin M; Pastore A; Rizzo R; Baricordi OR
Am J Rhinol; 2008; 22(5):468-73. PubMed ID: 18954504
[TBL] [Abstract][Full Text] [Related]
27. Plasma soluble HLA-G is a potential biomarker for diagnosis of colorectal, gastric, esophageal and lung cancer.
Cao M; Yie SM; Liu J; Ye SR; Xia D; Gao E
Tissue Antigens; 2011 Aug; 78(2):120-8. PubMed ID: 21726203
[TBL] [Abstract][Full Text] [Related]
28. Importance of the plasma soluble HLA-G levels for prognostic stratification with traditional prognosticators in colorectal cancer.
Li JB; Ruan YY; Hu B; Dong SS; Bi TN; Lin A; Yan WH
Oncotarget; 2017 Jul; 8(30):48854-48862. PubMed ID: 28415627
[TBL] [Abstract][Full Text] [Related]
29. Soluble human leukocyte antigen-g expression and glucose tolerance in subjects with different degrees of adiposity.
Solini A; Muscelli E; Stignani M; Melchiorri L; Santini E; Rossi C; Astiarraga BD; Rizzo R; Baricordi OR
J Clin Endocrinol Metab; 2010 Jul; 95(7):3342-6. PubMed ID: 20427497
[TBL] [Abstract][Full Text] [Related]
30. Detection of soluble HLA-G molecules in plasma and amniotic fluid.
Rebmann V; Pfeiffer K; Pässler M; Ferrone S; Maier S; Weiss E; Grosse-Wilde H
Tissue Antigens; 1999 Jan; 53(1):14-22. PubMed ID: 10082427
[TBL] [Abstract][Full Text] [Related]
31. Association between serum levels of 12 different cytokines and short-term efficacy of anti-PD-1 monoclonal antibody combined with chemotherapy in advanced gastric cancer.
Qi Q; Peng Y; Zhu M; Zhang Y; Bao Y; Zhang X; Zhang J; Liu Y
Int Immunopharmacol; 2023 Jan; 114():109553. PubMed ID: 36516540
[TBL] [Abstract][Full Text] [Related]
32. Elevation of human leukocyte antigen-G expression is associated with the severe encephalitis associated with neurogenic pulmonary edema caused by Enterovirus 71.
Zheng XQ; Chen XQ; Gao Y; Fu M; Chen YP; Xu DP; Lin A; Yan WH
Clin Exp Med; 2014 May; 14(2):161-7. PubMed ID: 23605689
[TBL] [Abstract][Full Text] [Related]
33. Secretion of sHLA-G molecules in malignancies.
Rebmann V; Regel J; Stolke D; Grosse-Wilde H
Semin Cancer Biol; 2003 Oct; 13(5):371-7. PubMed ID: 14708717
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic significance of soluble human leukocyte antigen-G for gastric cancer.
Pan YQ; Ruan YY; Peng JB; Han QY; Zhang X; Lin A; Yan WH
Hum Immunol; 2016 Apr; 77(4):317-24. PubMed ID: 26788811
[TBL] [Abstract][Full Text] [Related]
35. HLA-G Expression in Tumor Tissues and Soluble HLA-G Plasma Levels in Patients with Gastrointestinal Cancer.
Farjadian S; Tabebordbar M; Mokhtari M; Safaei A; Malekzadeh M; Ghaderi A
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2731-2735. PubMed ID: 30360598
[TBL] [Abstract][Full Text] [Related]
36. Cytokines and Soluble HLA-G Levels in the Acute and Recovery Phases of Arbovirus-Infected Brazilian Patients Exhibiting Neurological Complications.
Almeida RS; Ferreira MLB; Sonon P; Cordeiro MT; Sadissou I; Diniz GTN; Militão-Albuquerque MFP; Franca RFO; Donadi EA; Lucena-Silva N
Front Immunol; 2021; 12():582935. PubMed ID: 33776990
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stem cells upregulate Treg cells via sHLA-G in SLE patients.
Chen C; Liang J; Yao G; Chen H; Shi B; Zhang Z; Zhao C; Zhang H; Sun L
Int Immunopharmacol; 2017 Mar; 44():234-241. PubMed ID: 28129605
[TBL] [Abstract][Full Text] [Related]
38. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
[TBL] [Abstract][Full Text] [Related]
39. Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells.
van der Meer A; Lukassen HG; van Cranenbroek B; Weiss EH; Braat DD; van Lierop MJ; Joosten I
Mol Hum Reprod; 2007 Feb; 13(2):123-33. PubMed ID: 17121749
[TBL] [Abstract][Full Text] [Related]
40. A Novel Prognostic Risk Model for Cervical Cancer Based on Immune Checkpoint HLA-G-Driven Differentially Expressed Genes.
Xu HH; Wang HL; Xing TJ; Wang XQ
Front Immunol; 2022; 13():851622. PubMed ID: 35924232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
